6th Jul 2021 11:30
OptiBiotix Health PLC - York, England-based developer of compounds to treat obesity, high cholesterol, diabetes and skincare - Signs exclusive distribution deal for CholBiome in South Korea. OptiBiotix subsidiary, ProBiotix Health Ltd enters into the agreement with Korean conglomerate Inscobee Inc. Inscobee sells and promotes nutraceuticals through hospitals and a distribution base through off-line channels such as Holland & Barrett stores and supermarkets.
"Inscobee is the ideal partner in the fast moving, highly dynamic and competitive South Korean health food markets where consumers seek innovative and effective natural solutions which stand out in the market," comments Commercial Director Mikkel Hvid-Hansen.
Current stock price: 51.50 pence
Year-to-date change: down 11%
By Will Paige; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
OptiBiotix Health